Notably, treatment with metformin, insulin, or a combination of both was associated with failure to normalise glucose levels in all patients and the hyperglycaemia observed was more pronounced in patients with T2D and high CRP levels. This evidence concerns the gene CRP and type 2 diabetes mellitus.